This regulation governs Medicaid reimbursement and operational requirements for methadone services delivered within certified Opioid Treatment Programs (OTPs) in the District of Columbia. Facilities must be certified by DBH as an OTP and comply with 42 CFR Part 8, deliver methadone in conjunction with substance use disorder counseling, and follow ASAM and DBH practice guidelines. Reimbursement is on a per-service unit basis covering both medication and administration costs. Take-home doses are permitted based on clinical indications but may not exceed federal regulatory limits.
View official source9105 METHADONE SERVICES IN OPIOID TREATMENT PROGRAMS 9105.1 Methadone is a medication used in Medication Assisted Treatment (MAT) of opioid use disorder (OUD). 9105.2 Methadone services in opioid treatment programs shall: Be delivered in conjunction with counseling/therapy for substance use disorders; Be reimbursed using a per-service unit, that includes the cost of the medication and medication administration; and Be delivered in accordance with the American Society of Addiction Medicine service guidelines, and practice guidelines issued by DBH. 9105.3 Methadone services described in this section shall be delivered in facilities that: Meet the requirements for Opioid Treatment Programs in 42 CFR Part 8; and Are certified by DBH as an Opioid Treatment Program. 9105.4 An individual may receive take-home doses of methadone as determined by clinical indications for the individual. The number of take-home doses may not exceed the limits established by federal regulations. SOURCE: Final Rulemaking published at 59 DCR 11144 (September 28, 2012); as amended by Final Rulemaking published at 63 DCR 11655 (September 23, 2016); as amended by Final Rulemaking published at 72 DCR 013719 (December 5, 2025). District of Columbia Municipal Regulations Public Welfare 29 DCMR § 9105